Bank of New York Mellon’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-169,284
| Closed | -$874K | – | 4306 |
|
|
2019
Q2 | $874K | Buy |
169,284
+2,829
| +2% | +$12.7K | ﹤0.01% | 3310 |
|
|
2019
Q1 | $599K | Buy |
166,455
+2,273
| +1% | +$9.85K | ﹤0.01% | 3465 |
|
|
2018
Q4 | $1.01M | Buy |
164,182
+16,270
| +11% | +$99.3K | ﹤0.01% | 3096 |
|
|
2018
Q3 | $864K | Sell |
147,912
-705
| -0.5% | -$3.52K | ﹤0.01% | 3359 |
|
|
2018
Q2 | $632K | Buy |
148,617
+3,180
| +2% | +$16K | ﹤0.01% | 3511 |
|
|
2018
Q1 | $641K | Buy |
145,437
+879
| +0.6% | +$3.92K | ﹤0.01% | 3456 |
|
|
2017
Q4 | $760K | Buy |
144,558
+5,496
| +4% | +$33.6K | ﹤0.01% | 3405 |
|
|
2017
Q3 | $853K | Buy |
139,062
+1,960
| +1% | +$12.4K | ﹤0.01% | 3313 |
|
|
2017
Q2 | $992K | Buy |
137,102
+11,229
| +9% | +$69.1K | ﹤0.01% | 3258 |
|
|
2017
Q1 | $667K | Sell |
125,873
-3,786
| -3% | -$25.6K | ﹤0.01% | 3439 |
|
|
2016
Q4 | $931K | Sell |
129,659
-7,642
| -6% | -$61.8K | ﹤0.01% | 3298 |
|
|
2016
Q3 | $1.28M | Buy |
137,301
+437
| +0.3% | +$3.63K | ﹤0.01% | 3040 |
|
|
2016
Q2 | $866K | Buy |
136,864
+19,590
| +17% | +$126K | ﹤0.01% | 3242 |
|
|
2016
Q1 | $647K | Sell |
117,274
-12,818
| -10% | -$48.2K | ﹤0.01% | 3311 |
|
|
2015
Q4 | $726K | Sell |
130,092
-24,525
| -16% | -$162K | ﹤0.01% | 3355 |
|
|
2015
Q3 | $1.31M | Sell |
154,617
-9,976
| -6% | -$169K | ﹤0.01% | 3014 |
|
|
2015
Q2 | $2.49M | Sell |
164,593
-33,899
| -17% | -$489K | ﹤0.01% | 2766 |
|
|
2015
Q1 | $3.18M | Buy |
198,492
+2,482
| +1% | +$44.2K | ﹤0.01% | 2570 |
|
|
2014
Q4 | $3.49M | Buy |
196,010
+63,421
| +48% | +$790K | ﹤0.01% | 2506 |
|
|
2014
Q3 | $1.33M | Sell |
132,589
-2,806
| -2% | -$34K | ﹤0.01% | 3130 |
|
|
2014
Q2 | $2.11M | Buy |
135,395
+53,566
| +65% | +$759K | ﹤0.01% | 2876 |
|
|
2014
Q1 | $1.52M | Buy |
81,829
+50,995
| +165% | +$1.02M | ﹤0.01% | 3060 |
|
|
2013
Q4 | $589K | Buy |
30,834
+17,167
| +126% | +$349K | ﹤0.01% | 3519 |
|
|
2013
Q3 | $224K | Buy |
+13,667
| New | +$144K | ﹤0.01% | 3766 |
|
Other funds holding PETX
Bank of New York Mellon's PETX Position: Q3 2019 in Review
Bank of New York Mellon sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 169,284 shares — an estimated $874K sold.
Bank of New York Mellon first reported a position in PETX in Q3 2013 and held it in 24 quarters. The position peaked at $3.49M in Q4 2014. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.
- Bank of New York Mellon reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
- Bank of New York Mellon sold 169,284 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $874K.
- Bank of New York Mellon first reported a position in Aratana Therapeutics, Inc. in Q3 2013 and held it in 24 quarters.
- Bank of New York Mellon's Aratana Therapeutics, Inc. position peaked at $3.49M in Q4 2014.
- 2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.
Based on Bank of New York Mellon's 13F filing for Q3 2019, filed 7 Nov 2019.